News | Magnetic Resonance Imaging (MRI) | July 05, 2018

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

While new research suggests ultra-high-field 7T MRI could pose problems for people with amalgam fillings, conventional 1.5T scans were found to be safe

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

July 5, 2018 — Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in teeth, according to a new study appearing online in the journal Radiology. The effect was not seen, however, in the lower strength, more commonly used 1.5-Tesla (T) MRI.

Amalgam fillings, also known as silver fillings, have been a staple of dentistry for many years. Amalgam consists of approximately 50 percent mercury, a known toxin that can cause a host of harmful effects in humans. Despite the presence of mercury, the U.S. Food and Drug Administration (FDA) considers amalgam fillings safe for adults and children older than age six.

“In a completely hardened amalgam, approximately 48 hours after placing on teeth, mercury becomes attached to the chemical structure, and the surface of the filling is covered with an oxide film layer,” said the study’s lead author, Selmi Yilmaz, Ph.D., a dentist and faculty member at Akdeniz University in Antalya, Turkey. “Therefore, any mercury leakage is minimal.”

Previous research has found that exposure to the magnetic fields of MRI could cause mercury to leak from amalgam fillings. This concern has been heightened by the recent arrival of ultra-high-strength 7T scanners in the clinic. The stronger magnetic field of 7T MRI yields more anatomical detail, but its effects on amalgam dental fillings have not been studied.

To learn more, Yilmaz and colleague, Mehmet Zahit Adişen, Ph.D., evaluated mercury released from dental amalgam after 7T and 1.5T MRI in teeth that had been extracted from patients for clinical indications. While 7T MRI was approved by the FDA in 2017, it has extremely limited availability. The lower-strength 1.5T MRI is widely available and commonly used for patient exams.

The researchers opened two-sided cavities in each tooth and applied amalgam fillings. After nine days, two groups of 20 randomly selected teeth were placed in a solution of artificial saliva immediately followed by 20 minutes of exposure to 1.5T or 7T MRI. A control group of teeth was placed in artificial saliva only.

When the researchers analyzed the artificial saliva, the mercury content in the 7T, 1.5T and control group was 0.67 ± 0.18, 0.17 ± 0.06 and 0.14 ± 0.15 parts per million (ppm), respectively.  At 0.67 ppm, the mercury content in the 7T group was approximately four times the levels found in the 1.5T group and the control group.

“In our study, we found very high values of mercury after ultra-high-field MRI,” Yilmaz said. “This is possibly caused by phase change in amalgam material or by formation of microcircuits, which leads to electrochemical corrosion, induced by the magnetic field.”

An important point of discrimination concerning safety and hazard to human health is the amount of mercury that is absorbed by the vital tissues.

“It is not clear how much of this released mercury is absorbed by the body,” Yilmaz said.

Further studies may be warranted, Yilmaz added, to evaluate the relationship between high-field MRI and release of mercury from dental amalgam. The researchers have three ongoing projects focused on phase and temperature changes of dental amalgam across different magnetic fields.

As no evidence of harmful effects was found in the 1.5T group, patients with amalgam fillings should not be unduly concerned about having an MRI exam.

For more information: www.pubs.rsna.org/journal/radiology

Reference

Yilmaz S., Adisen M.Z. "Ex Vivo Mercury Release from Dental Amalgam after 7.0-T and 1.5-T MRI," Radiology. June 26, 2018. https://doi.org/10.1148/radiol.2018172597

Related Content

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...